Cardiovascular Disease Expected to Increase in the Coming Decades

/in , , /by

Heart disease has held the title of the world’s leading cause of death for over a century. Unfortunately, the future does not seem to offer any relief from this statistic. Read more

Dr. Abkin Joins New York Bariatric Group

/in , , /by

We’re thrilled to announce some exciting news! Advanced Laparoscopic Surgeons of Morris has officially joined New York Bariatric Group (NYBG), the nation’s leading provider of bariatric services. This collaboration marks a significant stride in our dedication to delivering cutting-edge surgical techniques and exceptional patient care.

Dr. Alexander Abkin and his team from Advanced Laparoscopic Surgeons of Morris will now be part of the esteemed NYBG team, which boasts 25 renowned bariatric surgeons. NYBG is well known for its patient-centered approach to weight-loss, offering a comprehensive range of services including expedited one-day presurgical assessments, aftercare programs, support groups, and nutritional guidance.

In addition, the introduction of ambulatory surgery centers (ASC) will greatly enhance the patient experience, providing a state-of-the-art facility for same-day surgical procedures. These ASCs offer a superior alternative to traditional hospital stays, ensuring a safe and comfortable surgical journey.

We’re genuinely excited about this partnership and the opportunities it presents to enhance our service to you. If you have any questions or wish to schedule an appointment, please call 973-410-9700.

Sincerely,

Dr. Alexander Abkin
Advanced Laparoscopic Surgeons of Morris

As Zepbound Shortage Grows, Eli Lilly Says No Immediate End Is In Sight

/in , , /by

As the demand for weight loss medications surges, the availability of Zepbound, manufactured by Eli Lilly, faces significant shortages, with no immediate solution in sight. The FDA approved Zepbound in November, offering a new option for weight loss alongside Novo Nordisk’s Wegovy. However, despite earlier assurances from Lilly’s CEO, Dave Ricks, shortages have become widespread just months after approval. Read more

Why Bariatric Surgery May Be Better Than Wegovy and Zepbound

/in , , /by

Within the rise in popularity of weight loss medications like Zepbound and Wegovy is a less-noticed phenomenon: Some patients don’t lose much weight on them. Read more

Understanding Gastric Bypass: A Key to Diabetes Remission

/in , , /by

New research sheds light on the effectiveness of gastric bypass surgery in maintaining remission of type 2 diabetes, even if patients regain weight over time. Dr. Alexander Abkin, a leading bariatric surgeon in New Jersey, helps break down the findings for us. Read more

Why Mindful Eating is Better than Dieting

/in , , /by

Snack fever sets in — do you succumb, or shake it off?

For those who can’t seem to quit noshing on junk, experts say they have just the thing to break the cycle — a practice known as mindful eating. Read more

Weight Loss Surgery is Most Effective for Blood Pressure Control, Study Suggests

/in , , /by

A recent study published in the Journal of the American College of Cardiology found that people who have obesity often struggle with high blood pressure. However, those who undergo weight loss surgery, called bariatric surgery, tend to have better results in lowering their blood pressure compared to those who only rely on medication.” Read more

Exploring the Cognitive Impact of Bariatric Surgery: A Glimpse into Improved Executive Function

/in , , /by

Bariatric surgery has long been recognized as an effective intervention for sustained weight loss and improved metabolic health. Beyond its physical benefits, recent research delves into the potential cognitive effects of bariatric procedures. A recent study aimed to unravel the connection between bariatric surgery and cognitive outcomes, shedding light on whether this transformative surgery may influence cognitive decline in individuals with obesity. Read more

Bariatric Surgery: A Safer and More Effective Path to Sustained Weight Loss

/in , , /by

In recent years, the rising popularity of semaglutide has become a cause for concern, with poison control centers reporting a staggering increase in calls related to this drug. The surge, amounting to over 1,500% since 2019, has predominantly been attributed to dosage errors, leading to a nightmare scenario for both patients and healthcare providers. Read more

Study Finds Lower Risk for Hematologic Cancer in Woman After Bariatric Surgery

/in , , /by

A recent study published in Lancet Healthy Longevity suggests that bariatric surgery, a weight loss procedure, is linked to a lower risk of blood cancer, particularly in women. The research, involving over 2,000 individuals who underwent surgery and a similar group who did not, revealed a significant reduction in the incidence and mortality of blood cancers among those who had bariatric surgery. Notably, the benefit was more pronounced in women, especially those with high blood sugar levels at the beginning of the study. Read more